Robertson A, MacDonald C
Eur J Pharmacol. 1985 Feb 12;109(1):81-9. doi: 10.1016/0014-2999(85)90542-4.
The effects of the atypical neuroleptic sulpiride (0-20 mg/kg s.c.) and the classical neuroleptic metoclopramide (0-4 mg/kg s.c.) on behaviours produced by D-amphetamine (0-5 mg/kg i.p.) were measured in a time-sampling observational paradigm in rats. Sulpiride had one clear dose-dependent effect: it enhanced amphetamine-induced stereotyped behaviours (repetitive head movements, sniffing down and some gnawing). In contrast, metoclopramide dose-dependently decreased amphetamine-induced stereotypy, locomotion, rearing, and sniffing up, and concurrently antagonized the suppression of lying down produced by amphetamine. Sulpiride's facilitatory effects on amphetamine-induced stereotypy follow a pattern previously observed for two other atypical neuroleptics: clozapine and thioridazine. This may be a common effect of atypical neuroleptics. Since these neuroleptics are antipsychotic, amphetamine-induced stereotypy appears to be a poor animal model for human psychoses. It is suggested that sulpiride's effects may be mediated through a preferential presynaptic versus postsynaptic action on dopamine neurons in the nigrostriatal bundle.
在大鼠的时间抽样观察范式中,测量了非典型抗精神病药物舒必利(0 - 20毫克/千克,皮下注射)和经典抗精神病药物甲氧氯普胺(0 - 4毫克/千克,皮下注射)对由右旋苯丙胺(0 - 5毫克/千克,腹腔注射)产生的行为的影响。舒必利有一个明显的剂量依赖性效应:它增强了苯丙胺诱导的刻板行为(重复性头部运动、向下嗅探和一些啃咬)。相比之下,甲氧氯普胺剂量依赖性地减少了苯丙胺诱导的刻板行为、运动、竖毛和向上嗅探,并同时拮抗了苯丙胺对躺卧的抑制作用。舒必利对苯丙胺诱导的刻板行为的促进作用遵循了先前观察到的另外两种非典型抗精神病药物:氯氮平和硫利达嗪的模式。这可能是非典型抗精神病药物的共同作用。由于这些抗精神病药物具有抗精神病作用,苯丙胺诱导的刻板行为似乎不是人类精神病的良好动物模型。有人提出,舒必利的作用可能是通过对黑质纹状体束中多巴胺神经元的优先突触前与突触后作用介导的。